Non-profit · founded 1989
Seattle Institute for Biomedical and Clinical Research
Seattle, United States · sibcr.org
- Citations, last 5 years
- 178
- Works, last 5 years
- 26
- h-index
- 50
- Scientists listed
- 0
- Grants since 2016
- 159
Grants received
2017–2022 · research · R01
Defining the role of age-related glymphatic pathway impairment in amyloid beta plaque deposition
Jeffrey J Iliff · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2017–2020 · research · R03
Whole-methylome sequencing to identify unique epigenetic profiles in Lewy body dementias
Debby Wen Tsuang · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2017–2022 · research · R01
Defining the role of age-related glymphatic pathway impairment in amyloid beta plaque deposition
Jeffrey J Iliff · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2017–2018 · research · Grant-in-Aid
Effect of Moderate Hyperoxia on Neovessel Stability in Human Atherosclerosis-induced Angiogenesis
Roberto Nicosia · Seattle Institute for Biomedical and Clinical Research · funded by American Heart Association
2017–2022 · research · RF1
MSUT2 modulates pathological tau in AD and model organisms
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2017–2023 · research · R01
Defining the role of age-related glymphatic pathway impairment in amyloid beta plaque deposition
Jeffrey J Iliff · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2017–2019 · research · R03
Whole-methylome sequencing to identify unique epigenetic profiles in Lewy body dementias
Debby Wen Tsuang · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2016–2018 · research · R21
Mechanisms of Blood-brain Barrier Disruption in Type II Diabetes
William A Banks · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2016–2019 · research · R21
Mechanisms of Blood-brain Barrier Disruption in Type II Diabetes
William A Banks · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2015–2022 · research · R01
Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality?
George Ioannou · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2015–2021 · research · R01
Role of perivascular aquaporin-4 polarization in post-traumatic neurodegeneration
Jeffrey J Iliff · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2015–2020 · research · R01
Cognitive, Behavioral and Aging Effects of Opioids in Alcohol Users
Monique Cherrier · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2015–2021 · cooperative agreement · U01
Health through Obesity care for PatiEnts with COPD (HOPE)
David H Au · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2015–2021 · research · R01
Ancillary Study Proposal for The Restoring Insulin Secretion (RISE) Study: Autoimmune Mechanisms for the Progressive Decline of Beta cell Function in Type 2 Diabetes (T2D)
Jerry P Palmer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2014–2021 · research · R01
Intranasal Insulin in a Mouse Model of Alzheimer's Disease
William A Banks · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2013–2020 · research · R01
Impact of Neprilysin on Islet Function
Sakeneh Zraika · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2011–2020 · cooperative agreement · U01
Optimizing Recovery and Preservation of Endogenous Insulin Secretion
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2011–2020 · cooperative agreement · U01
Optimizing Recovery and Preservation of Endogenous Insulin Secretion
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2010–2020 · research · R01
Islet Endothelial Dysfunction in Diabetes
Rebecca Lucy Hull-Meichle · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2010–2022 · research · R01
Islet Endothelial Dysfunction in Diabetes
Rebecca Lucy Hull-Meichle · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2010–2020 · research · R01
Islet Endothelial Dysfunction in Diabetes
Rebecca Lucy Hull-Meichle · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2010–2020 · research · R01
Islet Endothelial Dysfunction in Diabetes
Rebecca Lucy Hull-Meichle · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2009–2023 · research · R01
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2009–2023 · research · R01
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2009–2023 · research · R01
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
2009–2025 · research · R01
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD
Brian C. Kraemer · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1999–2021 · cooperative agreement · U01
14/16 Action for Health in Diabetes Extension Study Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1999–2022 · cooperative agreement · U01
14/16 Action for Health in Diabetes Extension Study Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1999–2021 · cooperative agreement · U01
14/16 Action for Health in Diabetes Extension Study Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1999–2021 · cooperative agreement · U01
14/16 Action for Health in Diabetes Extension Study Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1999–2021 · cooperative agreement · U01
14/16 Action for Health in Diabetes Extension Study Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2023 · cooperative agreement · U01
8/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
1994–2021 · cooperative agreement · U01
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
Steven Emanuel Kahn · Seattle Institute for Biomedical and Clinical Research · funded by National Institutes of Health
